Work

Prostate-specific antigen outcomes of darolutamide and androgen deprivation therapy in patient subgroups by age, comorbidities, and concomitant medications: ARANOTE post hoc analyses.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.5103

Authors: Fred Saad, Kunhi Parambath Haresh, Egils Vjaters, Aly-Khan A. Lalani, Manjari Dissanayake, Isabella Testa, Sanjeeva Reddy, Kristin Fritsch, Neal D. Shore

Institutions: Université de Montréal, All India Institute of Medical Sciences, Pauls Stradiņš Clinical University Hospital, Juravinski Cancer Centre, McMaster University, Bayer (United States), Bayer (Italy), Bayer (Switzerland), Carolina Urologic Research Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162559637

Cites:

Cited by:

Related to: